News Focus
News Focus
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

Re: Regulardoc post# 15709

Friday, 08/05/2016 10:35:26 AM

Friday, August 05, 2016 10:35:26 AM

Post# of 20689
MNTA's 0-for-2 record on novel drugs is not great; OTOH, MNTA is 2-for-2 on reverse engineering complex drugs from other companies, both of which were accomplishments that many analysts and investors said could not be done.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”